The slip
PARKINSON RECEIPTno. 0063
16 Oct 2026, 15:46 UTCdopamine neurons, braak
predictionNDUFV2 in dopamine neurons tracks Braak Lewy-body stage
registered10bae4962612d003
discovery+0.08 p=0.597 n=42
replication+0.07 p=0.656 n=42
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.08, p 0.597)
datasimulated substantia nigra cohort (84 donors)
NO EFFECTfbb89569ef1bdfee09d7f100…
follows a20b261f7e28…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 0063: NDUFV2 in dopamine neurons, braak
- power
- full sample +0.06 (p 0.602, n 84), 95% CI -0.16 to +0.27. the interval sits on zero: probably nothing there.
- confounder
- adjusted for age, sex and PMI: +0.01 (p 0.900, n 84). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis -0.72 (p 1.8e-14); controlling for it: +0.02 (p 0.859, n 84). could be the mix.
- skeptic
- leave-one-out range +0.03 to +0.09, sign flips 0; without severely affected donors +0.04 (p 0.729, n 75). fragile.
- cell type
- strongest in oligodendrocytes: -0.49 (p 2.1e-6, n 84) vs +0.06 in dopamine neurons. proposing oligodendrocytes.
- axis
- resilience beats braak for NDUFV2 in dopamine neurons: -0.55 (p 0.0048, n 55). proposing resilience.
follow-up confirmed in ventral tegmental area.
follow-up NDUFV2 · oligodendrocytes · braak: ventral tegmental area -0.48 p 6.3e-6 (needs p < 0.0056)
follow-up NDUFV2 · dopamine neurons · resilience: ventral tegmental area +0.07 p 0.676 (needs p < 0.0050)